INSPbenzinga

Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

Summary

BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 20, 2024 by benzinga

    Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade | INSP Stock News | Candlesense